Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2007-7-16
pubmed:abstractText
Recent studies have shown that administration of granulocyte colony-stimulating factor (G-CSF) is neuroprotective. However, the precise mechanisms of the neuroprotective effect of G-CSF are not entirely known. We carried out 90-min transient middle cerebral occlusion (tMCAO) of rats. The rats were injected with vehicle or G-CSF (50 mug/kg) immediately after reperfusion and sacrificed 8, 24, or 72 hr later. 2,3,5-Triphenyltetrazolium chloride (TTC) staining was carried out using brain sections of 72 hr, and immunohistochemistry was carried out with those of 8, 24, and 72 hr. TTC-staining showed a significant reduction of infarct volume in the G-CSF-treated group (**P < 0.01). Immunohistochemistry showed a significant decrease of the number of cells expressing tumor necrosis factor-alpha (TNF-alpha) at 8-72 hr, transforming growth factor-beta (TGF-beta) and inducible nitric oxide synthase (iNOS) at 24 and 72 hr after tMCAO in the peri-ischemic area (*P < 0.05 each). Our data suggest that the suppression of inflammatory cytokines and iNOS expression may be one mechanism of neuroprotection by G-CSF.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0360-4012
pubmed:author
pubmed:copyrightInfo
(c) 2007 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2167-74
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17497673-Animals, pubmed-meshheading:17497673-Anti-Inflammatory Agents, pubmed-meshheading:17497673-Brain, pubmed-meshheading:17497673-Brain Ischemia, pubmed-meshheading:17497673-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:17497673-Immunohistochemistry, pubmed-meshheading:17497673-Infarction, Middle Cerebral Artery, pubmed-meshheading:17497673-Inflammation, pubmed-meshheading:17497673-Male, pubmed-meshheading:17497673-Nervous System, pubmed-meshheading:17497673-Neuroprotective Agents, pubmed-meshheading:17497673-Nitric Oxide Synthase Type II, pubmed-meshheading:17497673-Rats, pubmed-meshheading:17497673-Rats, Wistar, pubmed-meshheading:17497673-Stroke, pubmed-meshheading:17497673-Time Factors, pubmed-meshheading:17497673-Transforming Growth Factor beta, pubmed-meshheading:17497673-Tumor Necrosis Factor-alpha
pubmed:year
2007
pubmed:articleTitle
Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats.
pubmed:affiliation
Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't